GT Biopharma
GTBP
GTBP
34 hedge funds and large institutions have $4.36M invested in GT Biopharma in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
87% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 15
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$83.4K | |
| 2 | +$63.4K | |
| 3 | +$51K | |
| 4 |
Goldman Sachs
New York
|
+$36.6K |
| 5 |
State Street
Boston,
Massachusetts
|
+$22.2K |
Top Sellers
| 1 | -$333K | |
| 2 | -$242K | |
| 3 | -$230K | |
| 4 |
Renaissance Technologies
New York
|
-$193K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$182K |